Big Pharma’s fight against drug price reforms takes weird, desperate turn

Q: How long will it take to read this news story?

The story "Big Pharma’s fight against drug price reforms takes weird, desperate turn" has 189 words across 32 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Big Pharma’s fight against drug price reforms takes weird, desperate turn" was covered 6 days ago by Ars Technica, a news publisher based in United States.

Q: How trustworthy is 'Ars Technica' news outlet?

Ars Technica is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news. The outlet is headquartered in United States and publishes an average of 2 news stories per day. It's most recent story was published 22 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21405476</li><li>URL: https://beamstart.com/news/big-pharmas-fight-against-drug-17195300579284</li></ul>

Ars Technica 6d ago

Big Pharma’s fight against drug price reforms takes weird, desperate turn - Ars Technica

Quick Summary:

PhRMA claims price negotiations raise costs and that drug patents lower them.

Milliman, the consulting firm PhRMA commissioned to do the study, cautioned that the actual prices "will certainly vary due to differences in unit cost and utilization trend, 2026 benefit designs, and actual 2026 maximum fair prices".

Enlarge / Stephen Ubl, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), speaks during a Bloomberg Live discussion in Washington, DC, in 2017.